134 related articles for article (PubMed ID: 36825353)
1. Long-term outcome of liver transplantation for autoimmune hepatitis: A French nationwide study over 30 years.
Chouik Y; Chazouillères O; Francoz C; De Martin E; Guillaud O; Abergel A; Altieri M; Barbier L; Besch C; Conti F; Corpechot C; Dharancy S; Durand F; Duvoux C; Gugenheim J; Hardwigsen J; Hilleret MN; Houssel-Debry P; Kamar N; Maucort-Boulch D; Minello A; Neau-Cransac M; Pageaux GP; Radenne S; Roux O; Saliba F; Serée O; Samuel D; Vanlemmens C; Woehl-Jaegle ML; Leroy V; Duclos-Vallée JC; Dumortier J
Liver Int; 2023 May; 43(5):1068-1079. PubMed ID: 36825353
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune hepatitis recurrence after liver transplantation: "Les jeux sont faits".
Chouik Y; Corpechot C; Francoz C; De Martin E; Guillaud O; Abergel A; Altieri M; Barbier L; Besch C; Chazouillères O; Conti F; Dharancy S; Durand F; Duvoux C; Gugenheim J; Hardwigsen J; Hilleret MN; Houssel-Debry P; Kamar N; Minello A; Neau-Cransac M; Pageaux GP; Radenne S; Roux O; Saliba F; Samuel D; Vanlemmens C; Woehl-Jaegle ML; Leroy V; Duclos-Vallée JC; Dumortier J
Liver Transpl; 2024 Apr; 30(4):395-411. PubMed ID: 37788303
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation.
Montano-Loza AJ; Ronca V; Ebadi M; Hansen BE; Hirschfield G; Elwir S; Alsaed M; Milkiewicz P; Janik MK; Marschall HU; Burza MA; Efe C; Calışkan AR; Harputluoglu M; Kabaçam G; Terrabuio D; de Quadros Onofrio F; Selzner N; Bonder A; Parés A; Llovet L; Akyıldız M; Arikan C; Manns MP; Taubert R; Weber AL; Schiano TD; Haydel B; Czubkowski P; Socha P; Ołdak N; Akamatsu N; Tanaka A; Levy C; Martin EF; Goel A; Sedki M; Jankowska I; Ikegami T; Rodriguez M; Sterneck M; Weiler-Normann C; Schramm C; Donato MF; Lohse A; Andrade RJ; Patwardhan VR; van Hoek B; Biewenga M; Kremer AE; Ueda Y; Deneau M; Pedersen M; Mayo MJ; Floreani A; Burra P; Secchi MF; Beretta-Piccoli BT; Sciveres M; Maggiore G; Jafri SM; Debray D; Girard M; Lacaille F; Lytvyak E; Mason AL; Heneghan M; Oo YH;
J Hepatol; 2022 Jul; 77(1):84-97. PubMed ID: 35143897
[TBL] [Abstract][Full Text] [Related]
4. Liver transplantation for autoimmune hepatitis: Pre-transplant does not predict the early post-transplant outcome.
Chouik Y; Francoz C; De Martin E; Guillaud O; Abergel A; Altieri M; Barbier L; Besch C; Chazouillères O; Conti F; Corpechot C; Dharancy S; Durand F; Duvoux C; Gugenheim J; Hardwigsen J; Hilleret MN; Houssel-Debry P; Kamar N; Minello A; Neau-Cransac M; Pageaux GP; Radenne S; Roux O; Saliba F; Samuel D; Vanlemmens C; Woehl-Jaegle ML; Leroy V; Duclos-Vallée JC; Dumortier J
Liver Int; 2023 Apr; 43(4):906-916. PubMed ID: 36577700
[TBL] [Abstract][Full Text] [Related]
5. 'De novo' and 'recurrent' autoimmune hepatitis after liver transplantation: A comprehensive review.
Kerkar N; Yanni G
J Autoimmun; 2016 Jan; 66():17-24. PubMed ID: 26377632
[TBL] [Abstract][Full Text] [Related]
6. A two decade long study of disease progression of de novo and recurrent autoimmune hepatitis in the pediatric population.
Hadley TA; Palle SK; Venkateswaran S; Abramowsky C; Gillespie S; Hall L; Kolachala VL; Gupta NA
Pediatr Transplant; 2021 Aug; 25(5):e13978. PubMed ID: 33522659
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for developing de novo autoimmune hepatitis associated with anti-glutathione S-transferase T1 antibodies after liver transplantation.
Salcedo M; Rodríguez-Mahou M; Rodríguez-Sainz C; Rincón D; Alvarez E; Vicario JL; Catalina MV; Matilla A; Ripoll C; Clemente G; Bañares R
Liver Transpl; 2009 May; 15(5):530-9. PubMed ID: 19399747
[TBL] [Abstract][Full Text] [Related]
8. Histologic surveillance after liver transplantation due to autoimmune hepatitis.
Puustinen L; Boyd S; Arkkila P; Isoniemi H; Arola J; Färkkilä M
Clin Transplant; 2017 May; 31(5):. PubMed ID: 28235132
[TBL] [Abstract][Full Text] [Related]
9. Single-Center North American Experience of Liver Transplantation in Autoimmune Hepatitis: Infrequent Indication but Good Outcomes for Patients.
de Quadros Onofrio F; Neong E; Adebayo D; Kollmann D; Adeyi OA; Fischer S; Hirschfield GM; Hansen BE; Bhat M; Galvin Z; Lilly LB; Selzner N
J Can Assoc Gastroenterol; 2021 Jun; 4(3):137-144. PubMed ID: 34056531
[TBL] [Abstract][Full Text] [Related]
10. Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation.
Montano-Loza AJ; Vargas-Vorackova F; Ma M; Bain VG; Burak K; Kumar T; Mason AL
Liver Int; 2012 Oct; 32(9):1426-33. PubMed ID: 22712495
[TBL] [Abstract][Full Text] [Related]
11. Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus.
Tanaka A; Kono H; Leung PSC; Gershwin ME
Cell Immunol; 2020 Jan; 347():104021. PubMed ID: 31767117
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation for autoimmune hepatitis: a long-term pathologic study.
Ayata G; Gordon FD; Lewis WD; Pomfret E; Pomposelli JJ; Jenkins RL; Khettry U
Hepatology; 2000 Aug; 32(2):185-92. PubMed ID: 10915722
[TBL] [Abstract][Full Text] [Related]
13. Longterm Survival After Liver Transplantation for Autoimmune Hepatitis: Results From the European Liver Transplant Registry.
Heinemann M; Adam R; Berenguer M; Mirza D; Malek-Hosseini SA; O'Grady JG; Lodge P; Pratschke J; Boudjema K; Paul A; Zieniewicz K; Fronek J; Weiss KH; Karam V; Duvoux C; Lohse A; Schramm C;
Liver Transpl; 2020 Jul; 26(7):866-877. PubMed ID: 32112516
[TBL] [Abstract][Full Text] [Related]
14. Recurrent Autoimmune Hepatitis and De Novo Autoimmune Hepatitis in the Liver Allograft.
González IA; Hartley CP; Nalbantoglu I
Am J Clin Pathol; 2021 Feb; 155(3):435-445. PubMed ID: 33252121
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of pediatric liver transplantation for autoimmune liver disease.
Couchonnal E; Jacquemin E; Lachaux A; Ackermann O; Gonzales E; Lacaille F; Debray D; Boillot O; Guillaud O; Wildhaber BE; Chouik Y; McLin V; Dumortier J
Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101537. PubMed ID: 33077391
[TBL] [Abstract][Full Text] [Related]
16. Childhood autoimmune liver disease: indications and outcome of liver transplantation.
Chai PF; Lee WS; Brown RM; McPartland JL; Foster K; McKiernan PJ; Kelly DA
J Pediatr Gastroenterol Nutr; 2010 Mar; 50(3):295-302. PubMed ID: 20118802
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune Hepatitis in the Liver Transplant Graft.
Beal EW; Black SM; Michaels A
Clin Liver Dis; 2017 May; 21(2):381-401. PubMed ID: 28364820
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of liver transplantation for autoimmune hepatitis.
Vogel A; Heinrich E; Bahr MJ; Rifai K; Flemming P; Melter M; Klempnauer J; Nashan B; Manns MP; Strassburg CP
Clin Transplant; 2004 Feb; 18(1):62-9. PubMed ID: 15108772
[TBL] [Abstract][Full Text] [Related]
19. Recurrent and De Novo Autoimmune Hepatitis.
Stirnimann G; Ebadi M; Czaja AJ; Montano-Loza AJ
Liver Transpl; 2019 Jan; 25(1):152-166. PubMed ID: 30375180
[TBL] [Abstract][Full Text] [Related]
20. Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease.
Krishnamoorthy TL; Miezynska-Kurtycz J; Hodson J; Gunson BK; Neuberger J; Milkiewicz P; Oo YH
Liver Transpl; 2016 Jan; 22(1):34-41. PubMed ID: 26335026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
